##
##
##
##
|||||Pages|
|---|---|---|---|---|
|Report ofthe Chair||||2-3|
|Report ofthe Trustees||||4-14|
|Independent
Auditor's|Report|||15-20|
|Statement of FinancialActi|dtles||(including the Income and Expenditure|account)|21|
|Balance Sheet||||22-23|
|Statement ofCash Flows||||24|
|Notes to rhe Financial|Statements|||25-36|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|AR ENDED 31MARCH 2|023||||||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total funds|Total funds|
|||Note|Income
Fund|Income|2023|2022|
|||||Fund|||
|Income and endowments|from:||||||
|Donations
and legacies|||586,627|497,995|1,084,622|1,053,821|
|Activities for generating|funds||254,711||254,711|172,872|
|Investments|||23,992||23,992|535|
|Total income and endowments|||865,330|497,995|1,363,325|1,227,228|
|Expenditure
on:|||||||
|Raising funds||7|277,217||277,217|265,093|
|Charitable
activities||7|450,315|628,235|1,078,550|796,242|
|Total expenditure||7|727,532|628,235|1,355,767|1,061,335|
|Net gains/(losses)
on investments|||(12,440)||(12,440)|104,658|
|Net income/(expenditure)|||125,358|[130,240)|(4,882)|270,551|
|Transfers
between funds|||||||
|Net movement
in funds|||125,358|(130,240)|(4,882)|270,551|
|Recondliation
offunds:|||||||
|Total Funds at31March|2022||2,096,785|282,167|2,378,952|2,108,401|
|Total funds at31March|2023||2,222,143|151,927|2,374,070|2,378,952|
##
##
##
##
##
|31MARCH|2023||||||||
|---|---|---|---|---|---|---|---|---|
||||||Unrestricte|Restricted|Total|Total|
|||||Note|d Income|Income|funds|funds|
||||||Fund|Fund|2023|2022|
|Fixed assets|||||||||
|Tangible assets||||1'1|9,240||9,240|12,104|
|Investments||||12|1,826,007|613,453|2,439,460|2,433,525|
||||||1,835,247|613,453|2,448,700|2,445,629|
|Current assets|||||||||
|Stocks||||13|13,012||13,012|8,505|
|Debtors||||14|145,694||145,694|64,874|
|Cash at bank|and in|hand||15|270,321||270,321|339,096|
||||||429,027||429,027|412,475|
|Liabilities:|||||||||
|Creditors: Amounts||falling due vvithin one||16|(42,131)|(222,018)|(264,'149)|(239,787)|
|year|||||||||
|Net current|assets/(liabilities)||||386,896|(222,018)|164,878|172,688|
|Total assets|less current||liabilities||2,222,143|391,435|2,613,578|2,618,317|
|Creditors: Amounts||falling due after more||17||(239,508)|(239,508)|(239,365)|
|than one year|||||||||
|Net assets/(liabilities)|||||2,222,143|151,927|4374,070|2,378,952|
|Charity Funds|||||||||
|Unrestricted|funds||||2,216,208||2,216,208|1,991,656|
|Revaluation|reserve||||5,935||5,935|105,129|
|Restricted funds||||22||151,927|151,927|282,167|
|Total charity|funds||||2,222,143|151,927|2,374,070|2,378,952|
##
##
##
##
##
||||Total funds|Total funds|
|---|---|---|---|---|
|||Note|2023|2022|
||||E||
|carhflow from operating|activities|18|(71,900)|154,0S1|
|Cash flew from investing|activities||||
|Interest received|||23,992|S35|
|Payments to acquire oftangible fixed assets|||(2,492)|(6,489)|
|Receipts from sales oftangible assets|||||
|Payments to acquire investments|||(18,375)|(471)|
|Receipts from sale ofinvestments|||||
|Net cash flow from investing
activities|||3,125|(6,425)|
|Change
in cash and cash equivalents|||(68,775)|147,626|
|Cash and cash equivalents|brought
forward||339,096|191,470|
|Cash and cash equivalents|carried forward||270,321|339,096|
|Cash and cash equivalents|consist of;||||
|Cash at bank and in hand|||270,321|339,096|
|Short term deposits|||||
|Cash and cash equivalents|at31March 2023||270,321|339,096|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Income|from donations
and legacies|||||
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||Income|Incan)e|2023|2022|
|||Fund|Fund|||
|||f|E|f|f|
|Donatians|and legacies|||||
|Donations|under the Gift Aid scheme|76,385||76,385|64,933|
|Legacy donations||43,497||43,497|135,408|
|Memoriam|donations|'213,585|3,635|217,220|218,494|
|Other danations||253,160|494,360|747,520|634,986|
|||'586,627|497,995|1,084,622|1,053,821|
##
##
##
##
||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|
||Income|Income|2023|2022|
||Fund|Fund|||
|Event income|241,374||241,374|158,410|
|Merchandise|13,337||13,337|14,462|
||254,711||254,711|172,872|
##
|Investment
inc|ome||||||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||Income|Income|2023|2022|
||||Fund|Fund|||
||||E|E|E|E|
|Interest receivable|from UK deposg|account|2,303||2,303|535|
|income receivable|from investment|fund|21,689||21,689||
|managers|||||||
||||23,992||23,992|535|
##
|Net inco|me/(expenditu|re)
and n|et movemarns
in funds have|been stated after charging|:|
|---|---|---|---|---|---|
|||||Total|Total|
|||||2023|2022|
|Depreciation|oftangible|fixed assets||5,356|4,629|
|(Profit)/loss|on fair value|movement|ofinvestments|12,440|(104,658)|
##
##
##
|.
Analysis ofreso|urces expended|||
|---|---|---|---|
|||Total|Total|
|||2023|2022|
|Cost ofgenerating|funds|||
|Merchandise||3,605|4,218|
|Events and catering||12,912|5,907|
|Salaries||133,962|139,757|
|PR and Marketing||5,772|3,560|
|Support costs||120,966|111,651|
|||277,217|265,093|
|||Direct|Support|Total|Total|
|---|---|---|---|---|---|
|||activities|costs|2023|2022|
|||f|f|f||
|Charitable|aclivities|||||
|Research||473,579|19,245|492,824|307,836|
|Info and patient support||451,015|134,711|585,726|488,406|
|||924,594|153,956|1,078,550|796,242|
##
||||Cost of|Research|Info and|Total|
|---|---|---|---|---|---|---|
||||generating||patient||
||||funds||support||
||||||E||
|Bookkeeping|and administration|fees|528||588|1,200|
|Rent|||13,226|2,104|14I729|30,059|
|Office costs|||77,080|12,263|85I839|175,182|
|Sundry|||333|53|369|755|
|Governance|costs (see note 8)||29,799|4,741|33,186|67,726|
||||120,966|19,245|134,711|274,922|
##
##
##
||||Total|Total|
|---|---|---|---|---|
||||2023|2022|
|Auditor's|remuneration||4,774|4,203|
|Accountancy||fees|3,082|2,788|
|Professional||fees|24,238|31,251|
|Salaries|||35,299|25,739|
|Trustees'|Meetings||333|51|
||||67,726|64,032|
|Analysis ofgrants|||||
|---|---|---|---|---|
||Grants to|Direct|Support|Total|
||Institutions|costs|costs||
|||||E|
|Prof5Gentleman|133,103|||133,103|
|Prof A Lowit|98,629|||98,629|
|Prof C Proultakis|128,954|||128.954|
|Dr V Cheiban|87,280|||87,280|
||447,966|||447,966|
##
|. Staff costs
e average
number ofpersons employed
by the charity during|the year was:||
|---|---|---|
||Total|Total|
||'2023|2022|
||E||
|Office staff|10||
|Specialist nurses|6||
|Advocacy Office/Social Welfare Specialist|1||
||17|15|
##
##
##
|.
Staffcosts (continued)|||
|---|---|---|
||Total|Total|
||2023|2022|
|Gross wages|545,896|482,177|
|Social security|50,064|42,317|
|Pension costs|25,701|24,041|
||621,661|548,535|
##
|||Office|Patient|Total|
|---|---|---|---|---|
|||equipment|Aids||
|||E|||
|Cost or valuation|||||
|At April 2022||29,254|57,577|86,831|
|Additions||2,492||2,492|
|Disposals||(289)||(289)|
|At31March|2023|31,457|57,577|89,034|
|Depreciation|||||
|At April 2022||19,285|55,442|74,727|
|Charge forthe year||3,646|1,710|5,356|
|Elimination|on disposal|(289)||(289)|
|At 31March|2023|22,642|57)152|79,794|
|Net BookVa(ue|||||
|At 31Iviarch|2023|8,815|425|9,240|
|At 31IVlarch|2022|9,969|2,135|12,104|
##
##
##
##
|AR ENDED 3
2.Investments|1MARCH|20|23|||
|---|---|---|---|---|---|
|||||Total||
|||||2023||
|Cost or valuation||||||
|At 1April 2022||||2,433,525||
|Additions||||18,375||
|Disposals||||||
|Revaluation||||(12,440)||
|At 31March|2023|||2,439,460||
|Impairment||||||
|At 1April 2022 and 31March 2023||||||
|Carrying amount||||||
|At 31March|2023|||2,439p460||
|At 31Iviarch|2022|||2,433,525||
||||||Market|
|||||Cost|Value|
|||||31March|31March|
|||||2023|2023|
|The Trustees'|Investments||were made up as|||
|follows:||||||
|CCLA||||2,005,027|2,439,460|
|||||2,005,027|2,439,460|
|||||31March|31March|
|||||2023|2022|
|Investments|at fair value||compdse:|||
|Equities||||1,102,135|1,114,575|
|Cash with Investment||portfolio||1,337,325|1,318,950|
|||||2,439,460|2,433,525|
##
##
##
|2023|2022|
|---|---|
||6|
|13,012|8,505|
|.Stock|2023
|2022
6
|
|---|---|---|
|Finished goods: Merchandise|13,012|8,505|
|,Debtors|||
||2023|2022|
|||E|
|Other debtors|125,694|22,345|
|Accrued income|20,000|42,529|
||145,694|64,874|
##
##
|.Cash at ban'k|||||||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||Income|income|funds|funds|
||||funds|funds|2023|2022|
|||||E|E||
|Cash committed|for|research grant funding|||||
|Other cash|||?70,321||270,321|339,096|
||||270,321||270,321|339,096|
|.Creditors: amounts||falling due within one year|||||
||||||2023|2022|
||||||E|E|
|Accrual for research||grants|||222,018|209,801|
|Ot'her taxation|and|social security|||13,512|10,722|
|Ot'her creditors|||||28,619|19,264|
||||||264,149|239,787|
##
##
##
##
|,Credit|ors:|amounts|falling due after mora than one|year||
|---|---|---|---|---|---|
|||||2023|2022|
||||||E|
|Accrual|for|Research|grants|239,508|239,365|
|8,
Reconciiiat|ion o|fnet move|ment
in funds tonet cash flo|w from operating
activities||
|---|---|---|---|---|---|
|||||Total|Total|
|||||funds|funds|
|||||2023|2022|
|||||E|E|
|Movement
in|net funds|||(4,882)|270,551|
|Depreciation|oftangible fixed||assets|5,356|4,629|
|Interest receivable||||{23,992)|(535)|
|(Gains)/losses|on investments|||12,440|(104,6581|
|Decrease/(increase)||ln stocks||(4,507)|(935)|
|Decrease/(Increase)||in debtors||(80,820)|178,335|
|Increase/(Decrease)||in creditors||24,505|(193,336)|
|Net cash flow|from|operating|activities|(71,900)|154,051|
##
||||Total|Total|
|---|---|---|---|---|
||||funds|funds|
||||2023|2022|
|Within|one|year|2,404|2,404|
|Within|one|to five years|2,916|5,320|
||||5,320|7,724|
##
##
##
##
||Research|hiurse|Regin nai|Other|Total|Total|
|---|---|---|---|---|---|---|
|||specialists|Core||2023|2022|
|||E|E|E|||
|Brought forward funds|282,167||||282,167|244,710|
|Income arising in the year|317&726|36,951|49,068|94,250|497,995|474,364|
|Expenses paid during the year|(447,966)|(36,951)|(49,068)|(94,250)|(628,235)|(436,907)|
|Carried forward funds|151,927||||151,927|282,167|
##
|.Analysis|o|ffunds|||||||
|---|---|---|---|---|---|---|---|---|
|||||At1April|Incoming|Resources|Gains|At31|
|||||2022|resources|expended|and|March|
||||||||losses|2023|
||||||||E|f.|
|Analysis of||movements|in funds||||||
|Unrestricted||fund||2,096,785|865,330|(727,532)|(12,440)|2,222,143|
|Restricted|fund|||282,167|497,995|(628,235)||151,927|
##
##
##
##
||||Fixed|Net|Non-|Total|
|---|---|---|---|---|---|---|
||||assets|current|current||
|||||assets|creditors||
||||E|E|E|E|
|Unrestricted||fund|1,835,247|386,896||2,222,143|
|Restricted|fund||613,453|(222,018)|(239,508)|151,927|
||||2+48,700|164,878|(239,508)|2,374,070|
##
|Financia|I assets|2023|2022|
|---|---|---|---|
|Other debtors||125,694|22,345|
|||125,694|22,345|
|Financial|liabilities|2023|2022|
|Research|grants|461526|449,166|
|Other creditors||42,131|29,986|
|||503,657|479,153|
|ir transaction
value and subsequently
measure
closing quoted market price:|d
at their fair value as at the balance she|et date usin|
|---|---|---|
|Financial assets|2023|2022|
|||E|
|Investments|2,439,460|2,433,525|